PropertyValue
?:abstract
  • • Patients with an indication for chronic warfarin can safely continue warfarin therapy with appropriate precautions during the COVID-19 pandemic. • Chronic warfarin therapy is not associated with a higher rate of positively testing for SAR-CoV2. • Patients on warfarin during the COVID-19 pandemic maintained TTR rates consistent with those prior to the COVID-19 pandemic.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1016/j.thromres.2020.11.034
?:journal
  • Thromb_Res
?:license
  • els-covid
?:pdf_json_files
  • document_parses/pdf_json/1e02acde24ea1b8310e8a267e3d4819af33e9649.json
?:pmcid
?:pmid
?:pmid
  • 33310348.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Association of Anticoagulation Use with SARS-CoV2 Detection
?:type
?:year
  • 2020-12-02

Metadata

Anon_0  
expand all